WO2001038498A3 - A new genotype of hepatitis b virus - Google Patents
A new genotype of hepatitis b virus Download PDFInfo
- Publication number
- WO2001038498A3 WO2001038498A3 PCT/US2000/032108 US0032108W WO0138498A3 WO 2001038498 A3 WO2001038498 A3 WO 2001038498A3 US 0032108 W US0032108 W US 0032108W WO 0138498 A3 WO0138498 A3 WO 0138498A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- virus
- hepatitis
- sample
- genotype
- nucleic acid
- Prior art date
Links
- 241000700721 Hepatitis B virus Species 0.000 title abstract 6
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 238000001514 detection method Methods 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 238000009396 hybridization Methods 0.000 abstract 1
- 238000007899 nucleic acid hybridization Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00980687A EP1238061A2 (en) | 1999-11-24 | 2000-11-21 | A new genotype of hepatitis b virus |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16720699P | 1999-11-24 | 1999-11-24 | |
US60/167,206 | 1999-11-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001038498A2 WO2001038498A2 (en) | 2001-05-31 |
WO2001038498A3 true WO2001038498A3 (en) | 2002-01-24 |
Family
ID=22606391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/032108 WO2001038498A2 (en) | 1999-11-24 | 2000-11-21 | A new genotype of hepatitis b virus |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1238061A2 (en) |
WO (1) | WO2001038498A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9034841B2 (en) | 2011-04-21 | 2015-05-19 | Isis Pharmaceuticals, Inc. | Modulation of hepatitis B virus (HBV) expression |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2486420C (en) | 2002-06-14 | 2014-04-15 | Gen-Probe Incorporated | Compositions and methods for detecting hepatitis b virus |
JP2008525029A (en) * | 2004-12-22 | 2008-07-17 | ニュークレオニクス・インコーポレイテッド | HBV and HCV conserved sequences useful for gene silencing |
JOP20200092A1 (en) | 2014-11-10 | 2017-06-16 | Alnylam Pharmaceuticals Inc | HEPATITIS B VIRUS (HBV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF |
US11324820B2 (en) | 2017-04-18 | 2022-05-10 | Alnylam Pharmaceuticals, Inc. | Methods for the treatment of subjects having a hepatitis b virus (HBV) infection |
KR20210043647A (en) | 2018-08-13 | 2021-04-21 | 알닐람 파마슈티칼스 인코포레이티드 | Hepatitis B virus (HBV) dsRNA preparation composition and method of use thereof |
WO2021060450A1 (en) * | 2019-09-27 | 2021-04-01 | 富士レビオ株式会社 | Immunoassay for hepatitis b virus core-related antigen and kit therefor |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02163089A (en) * | 1988-12-15 | 1990-06-22 | Dai Ichi Seiyaku Co Ltd | Hbv-dna sequence and trans-genic animal |
-
2000
- 2000-11-21 WO PCT/US2000/032108 patent/WO2001038498A2/en not_active Application Discontinuation
- 2000-11-21 EP EP00980687A patent/EP1238061A2/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02163089A (en) * | 1988-12-15 | 1990-06-22 | Dai Ichi Seiyaku Co Ltd | Hbv-dna sequence and trans-genic animal |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Section Ch Week 199031, Derwent World Patents Index; Class B04, AN 1990-235346, XP002166266 * |
STUYVER LIEVEN ET AL: "A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness.", JOURNAL OF GENERAL VIROLOGY, vol. 81, no. 1, January 2000 (2000-01-01), pages 67 - 74, XP000993120, ISSN: 0022-1317 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9034841B2 (en) | 2011-04-21 | 2015-05-19 | Isis Pharmaceuticals, Inc. | Modulation of hepatitis B virus (HBV) expression |
US9127278B2 (en) | 2011-04-21 | 2015-09-08 | Isis Pharmaceuticals, Inc. | Modulation of hepatitis B virus (HBV) expression |
Also Published As
Publication number | Publication date |
---|---|
WO2001038498A2 (en) | 2001-05-31 |
EP1238061A2 (en) | 2002-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0875584A3 (en) | Nucleic acid assays | |
WO2001096608A8 (en) | Detection of nucleic acids by type-specific hybrid capture method | |
CA2191182A1 (en) | Oligonucleotide primers for amplifying hcv nucleic acid | |
MX2013008116A (en) | Quantifying frustration via a user interface. | |
JPH0398600A (en) | Detection of influenza virus a by polymerase chain reaction after reverse transcription of genetic region of virus blood corpuscle hemagglutinin | |
Weber et al. | Improved detection of hepatitis B virus surface antigen by a new rapid automated assay | |
CA2588581A1 (en) | Detection of nucleic acids from multiple types of human papillomaviruses | |
JP2690738B2 (en) | Nucleic acid detection method and device | |
EP0618924A1 (en) | Hbv amplifier probes for use in solution phase sandwich hybridization assays | |
CA2139070A1 (en) | Method for enhancing detection ability of nucleic acid assays employing polymerase chain reaction | |
WO2003002749A3 (en) | Methods for the simultaneous detection of hcv antigens and hcv antibodies | |
WO2003033735A3 (en) | Test strip assay system and method for the detection of specific nucleic acid sequences | |
EP1174523A3 (en) | Method for detecting an HBV-derived nucleic acid target sequence | |
WO2004020654A3 (en) | Solid phase based nucleic acid assays combining high affinity and high specificity | |
WO2001038498A3 (en) | A new genotype of hepatitis b virus | |
WO2003038121A3 (en) | Method for the detection of cytosine methylation in immobilised dna samples | |
WO2000050564A3 (en) | Method for extracting dna from dried specimens | |
WO2002004484A3 (en) | Hcv mosaic antigen composition | |
EP1500710A4 (en) | Method of detecting target nucleic acid | |
WO1991000868A1 (en) | Immobilised polynucleotides | |
CN109884304B (en) | CHA amplification reaction system of HCV core protein and ultra-sensitive visual detection method | |
Japanese Red Cross NAT Screening Research Group | Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors | |
ATE305522T1 (en) | DETECTION OF HUMAN PAPILLOMA VIRUSES | |
EP0922771A3 (en) | Method for the detection of large concentrations of a virus in blood plasma and/ or blood serum using the polymerase chain reaction | |
WO2000066774A3 (en) | Improved assay and reagents therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000980687 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000980687 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000980687 Country of ref document: EP |